Mesothelioma Clinical Trials Overview > Mesothelioma Clinical Trial List
Inhaled Doxorubicin in Treating Patients With Advanced Solid Tumors Affecting the Lungs
| Conditions: | Lung Cancer|Malignant Mesothelioma|Metastatic Cancer |
| Start Date: | June 1, 2000 |
| Phase: | Phase I |
| Status: | Completed |
| NCT ID: | NCT00020124 |
| Study Type: | Interventional |
| Intervention: | Drug: doxorubicin hydrochloride |
| Study Design: | Primary Purpose: Treatment |
| Results: | No Results Available |
| Sponsors: | National Cancer Institute (NCI) |
| Ages: | Adult|Senior |
| Enrollment: | 0 |
| Funded By: | NIH |
| First Received: | July 11, 2001 |
| End Date: | |
| Last Updated: | May 25, 2010 |
| Last Verified: | May 1, 2002 |
Mesothelioma
Lawsuit Evaluation
Lawsuit Evaluation
